Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer’s disease

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Galectins. Structure and function of a large family of animal lectins.

Barondes, S. H., Cooper, D. N., Gitt, M. A., & Leffler, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31891-4 · Cited by 1,498 · see citing works

Galectins as modulators of tumour progression

Liu, F., & Rabinovich, G. A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1527 · Cited by 1,435 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

Galectins: A family of animal β-galactoside-binding lectins

Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Drickamer, K., Felzi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K.-I., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90498-7 · Cited by 1,223 · see citing works

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 1,107 · see citing works

Metabolic Regulation of Brain Aβ by Neprilysin

Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works

The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade

Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870 · see citing works

Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867 · see citing works

Proteolytic processing and cell biological functions of the amyloid precursor protein

Strooper, B. D., & Annaert, W. G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1857 · Cited by 628 · see citing works

Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis

Viola, K. L., & Klein, W. L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1386-3 · Cited by 628 · see citing works

Galectins as modulators of cell adhesion

Hughes, R. C. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01289-5 · Cited by 416 · see citing works

Galectins: regulators of acute and chronic inflammation

Liu, F., & Rabinovich, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05131.x · Cited by 401 · see citing works

Extracellular functions of galectin-3

Ochieng, J., Furtak, V. A., & Lukyanov, P. A. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014082.99675.2f · Cited by 368 · see citing works

Microglia-secreted Galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation

Burguillos, M. A., Svensson, M., Schulte, T., Boza-Serrano, A., Garcia-Quintanilla, A., Kavanagh, E., Santiago, M., Viceconte, N., Oliva-Martin, M. J., Osman, A. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.012 · Cited by 365 · see citing works

Soluble Aβ oligomer production and toxicity

Larson, M. E., & Lesné, S. E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07478.x · Cited by 356 · see citing works

Role of focal adhesion kinase in integrin signaling

Guan, J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00051-4 · Cited by 352 · see citing works

Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity

Fändrich, M. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.006 · Cited by 339 · see citing works

Galectin-3 promotes adhesion of human neutrophils to laminin

Kuwabara, I., & Liu, F. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3939 · Cited by 336 · see citing works

Integrin-mediated short-term memory in Drosophila

Grotewiel, M. S., Beck, C., Wu, K. H., Zhu, X., & Davis, R. L. (1998) · Nature · doi:10.1038/35079 · Cited by 277 · see citing works

PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity

Liu, B., Mink, S. R., Wong, K. A., Stein, N., Getman, C., Dempsey, P. W., Wu, H., & Shuai, K. (2004) · Nature Immunology · doi:10.1038/ni1104 · Cited by 271 · see citing works

L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity

Massa, S. M., Cooper, D. N. W., Leffler, H., & Barondes, S. H. (1993) · Biochemistry · doi:10.1021/bi00052a033 · Cited by 262 · see citing works

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid

Halim, A., Brinkmalm, G., Rüetschi, U., Brinkmalm, A., Portelius, E., Zetterberg, H., Blennow, K., Larson, G., & Nilsson, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102664108 · Cited by 247 · see citing works

An Emerging Role for Galectins in Tuning the Immune Response: Lessons from Experimental Models of Inflammatory Disease, Autoimmunity and Cancer

Rabinovich, G. A., Liu, F. T., Hirashima, M., & Anderson, A. C. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01986.x · Cited by 244 · see citing works

Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis

Zhao, Q., Barclay, M., Hilkens, J., Guo, X., Barrow, H., Rhodes, J. M., & Yu, L. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-154 · Cited by 207 · see citing works

Extracellular Galectin-3 in Tumor Progression and Metastasis

Fortuna-Costa, A., Gomes, A. M., Kozlowski, E. O., Stelling, M. P., & Pavão, M. S. G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00138 · Cited by 204 · see citing works

Integrin Requirement for Hippocampal Synaptic Plasticity and Spatial Memory

Chan, C.-S., Weeber, E. J., Kurup, S., Sweatt, J. D., & Davis, R. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07107.2003 · Cited by 202 · see citing works

Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer’s disease?

Nalivaeva, N., Beckett, C. S., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 178 · see citing works

Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model

Brouillette, J., Caillierez, R., Zommer, N., Pires, C. A., Benilova, I., Blum, D. L., Strooper, B. D., & Buée, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5901-11.2012 · Cited by 173 · see citing works

Mechanisms of Transthyretin Inhibition of β-Amyloid AggregationIn Vitro

Li, X., Zhang, X., Ladiwala, A. R. A., Du, D., Yadav, J. K., Tessier, P. M., Wright, P. E., Kelly, J. W., & Buxbaum, J. N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2561-13.2013 · Cited by 143 · see citing works

R47H Variant of<i>TREM2</i>Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study

Korvatska, O., Leverenz, J. B., Jayadev, S., McMillan, P., Kurtz, I., Guo, X., Rumbaugh, M., Matsushita, M., Girirajan, S., Dorschner, M. O., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0979 · Cited by 137 · see citing works

Neprilysin and Amyloid Beta Peptide Degradation

Hersh, L. B., & Rodgers, D. W. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954703 · Cited by 127 · see citing works

The case for soluble Aβ oligomers as a drug target in Alzheimer's disease

Hefti, F. F., Goure, W. F., Jerecı̀ć, J., Iverson, K. S., Walicke, P. A., & Krafft, G. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.002 · Cited by 119 · see citing works

Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease

Klein, W. L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 107 · see citing works

Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Aβ fibril formation pathway

Lee, S., Fernández, E., & Good, T. A. (2007) · Protein Science · doi:10.1110/ps.062514807 · Cited by 104 · see citing works

Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease

Wang, X., Zhang, S., Lin, F., Chu, W., & Yue, S. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513495107 · Cited by 100 · see citing works

The role of Galectin-3 in α-synuclein-induced microglial activation

Boza‐Serrano, A., Reyes, J. F., Rey, N. L., Leffler, H., Bousset, L., Nilsson, U. J., Brundin, P., Venero, J. L., Burguillos, M. Á., & Deierborg, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0156-0 · Cited by 96 · see citing works

Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches

Salahuddin, P., Fatima, M. T., Abdelhameed, A. S., Nusrat, S., & Khan, R. H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.065 · Cited by 95 · see citing works

Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization

Chesneau, V., Vekrellis, K., Rosner, M. R., & Selkoe, D. J. (2000) · Biochemical Journal · doi:10.1042/bj3510509 · Cited by 91 · see citing works

The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity

Ostapchenko, V. G., Beraldo, F. H., Mohammad, A. H., Xie, Y., Hirata, P. H. F., Magalhães, A. C., Lamour, G., Li, H., Maciejewski, A., Belrose, J. C., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3214-13.2013 · Cited by 84 · see citing works

Galectin‐3 secreted by human umbilical cord blood‐derived mesenchymal stem cells reduces amyloid‐β42 neurotoxicity in vitro

Kim, J., Kim, D. H., Kim, D., Kim, J. H., Jeong, S. Y., Jeon, H. B., Lee, E. H., Yang, Y. S., Oh, W., & Chang, J. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.028 · Cited by 60 · see citing works

Brain‐Derived Neurotrophic Factor Enhances Bcl‐xL Expression Through Protein Kinase Casein Kinase 2‐Activated and Nuclear Factor Kappa B‐Mediated Pathway in Rat Hippocampus

Chao, C.-C., Ma, Y., & Lee, E. H. Y. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00431.x · Cited by 57 · see citing works

Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer’s disease

Tao, C.-C., Hsu, W., Ma, Y., Cheng, S. J., & Lee, E. H. Y. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.161 · Cited by 52 · see citing works

Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning

Tai, D. J. C., Hsu, W. L., Liu, Y. C., Ma, Y. L., & Lee, E. H. Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.290 · Cited by 47 · see citing works

Aβ42-Binding Peptoids as Amyloid Aggregation Inhibitors and Detection Ligands

Luo, Y., Vali, S., Sun, S., Chen, X., Liang, X., Drozhzhina, T., Александровна, П. Е., & Борисович, Б. И. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400011f · Cited by 45 · see citing works

Focal Adhesion Kinase Is Required, But Not Sufficient, for the Induction of Long-Term Potentiation in Dentate Gyrus NeuronsIn Vivo

Yang, Y. C., Ma, Y., Chen, S., Wang, C. W., & Lee, E. H. Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04072.2003 · Cited by 43 · see citing works

The role of Galectin-3 in ¿-synuclein-induced microglial activation

Boza‐Serrano, A., Reyes, J. F., Rey, N. L., Leffler, H., Bousset, L., Nilsson, U. J., Brundin, P., Venero, J. L., Burguillos, M. Á., & Deierborg, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/preaccept-1285543917141325 · Cited by 21 · see citing works

Galectin-3 Negatively Regulates Hippocampus-Dependent Memory Formation through Inhibition of Integrin Signaling and Galectin-3 Phosphorylation

Chen, Y., Ma, Y., Lin, C.-H., Cheng, S., Hsu, W., & Lee, E. H. Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00217 · Cited by 20 · see citing works

Smad4 SUMOylation is essential for memory formation through upregulation of the skeletal myopathy gene TPM2

Hsu, W., Ma, Y., Liu, Y., & Lee, E. H. Y. (2017) · BMC Biology · doi:10.1186/s12915-017-0452-9 · Cited by 13 · see citing works

EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques

Kim, H. Y., Kim, H., Jo, S., Lee, C. J., Choi, S. Y., Kim, D. J., & Kim, Y. (2015) · Nature Communications · doi:10.1038/ncomms9997

Synaptic degeneration in Alzheimer disease

Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504 · see citing works

APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints

Yin, Z., Rosenzweig, N., Kleemann, K. L., Zhang, X., Brandão, W., Margeta, M. A., Schroeder, C., Sivanathan, K. N., Silveira, S., Gauthier, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01627-6 · Cited by 202 · see citing works

Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration

Puigdellívol, M., Allendorf, D. H., & Brown, G. C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00162 · Cited by 145 · see citing works

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease

Rahman, M. A., Islam, K., Rahman, S., & Alamin, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02177-w · Cited by 121 · see citing works

COVID-19 and Alzheimer’s Disease

Ciaccio, M., Sasso, B. L., Scazzone, C., Gambino, C. M., Ciaccio, A. M., Bivona, G., Piccoli, T., Giglio, R. V., & Agnello, L. (2021) · Brain Sciences · doi:10.3390/brainsci11030305 · Cited by 111 · see citing works

Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease

Tan, Y., Zheng, Y., Xu, D., Sun, Z., Yang, H., & Yin, Q. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00592-7 · Cited by 100 · see citing works

Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases

Javanmehr, N., Saleki, K., Alijanizadeh, P., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02637-1 · Cited by 103 · see citing works

Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases

Soares, L. C., Al‐Dalahmah, O., Hillis, J. M., Young, C. C., Asbed, I., Sakaguchi, M., O’Neill, E. E., & Szele, F. G. (2021) · Cells · doi:10.3390/cells10113047 · Cited by 94 · see citing works

Trilobatin rescues cognitive impairment of Alzheimer’s disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway

Gao, J.-M., Zhang, X., Shu, G., Chen, N., Zhang, J., Xu, F., Li, F., Liu, Y., Wei, Y., He, Y., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00888-5 · Cited by 95 · see citing works

Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care

Toniolo, S., the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Scarioni, M., Lorenzo, F. D., Hort, J., Georges, J., Tomić, S., Nobili, F. M., & Frederiksen, K. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210335 · Cited by 85 · see citing works

Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology

Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83 · see citing works

Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior

Srejovic, I. M., Selaković, D., Jovicic, N. U., Jakovljevic, V. L., Lukić, M. L., & Rosic, G. L. (2020) · Biomolecules · doi:10.3390/biom10050798 · Cited by 77 · see citing works

Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the <scp>APPswePS1dE9</scp> mouse model

Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71 · see citing works

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 72 · see citing works

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease

Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 71 · see citing works

Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2

Chen, Y., Lad, E. M., Mathew, R., Shiraki, N., Littleton, S., Chen, Y., Hou, J., Schlepckow, K., Degan, S., Chew, L. A., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231011 · Cited by 72 · see citing works

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease

Jayaswamy, P. K., Vijaykrishnaraj, M., Patil, P., Alexander, L. M., Kellarai, A., & Shetty, P. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101791 · Cited by 69 · see citing works

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease

Boza-Serrano, A., Vrillon, A., Minta, K., Paulus, A., Camprubí-Ferrer, L., Garcia, M., Andreasson, U., Antonell, A., Wennström, M., Gouras, G., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02469-6 · Cited by 66 · see citing works

Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes

Kim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00589-x · Cited by 66 · see citing works

Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches

Gholami, A. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137532 · Cited by 51 · see citing works

Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro

Yin, Q., Chen, J., Ma, S., Dong, C., Zhang, Y., Hou, X., Li, S., & Liu, B. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s273858 · Cited by 46 · see citing works

Microglia‐derived galectin‐3 in neuroinflammation; a bittersweet ligand?

Rahimian, R., Béland, L., Sato, S., & Križ, J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21784 · Cited by 44 · see citing works

Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

Shi, H., Yin, Z., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Davis, M. R., Wilson, J. W., Margeta, M. A., Pitts, K. M., Herron, S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01439-z · Cited by 44 · see citing works

Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies

Annadurai, N., Sanctis, J. B. D., Hajdúch, M., & Das, V. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113756 · Cited by 41 · see citing works

SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk

Green, R. J., Mayilsamy, K., McGill, A. R., Martinez, T. E., Chandran, B., Blair, L. J., Bickford, P. C., Mohapatra, S. S., & Mohapatra, S. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.09.007 · Cited by 40 · see citing works

Galectin-3 aggravates microglial activation and tau transmission in tauopathy

Siew, J. J., Chen, H.-M., Chiu, F., Lee, C., Chang, Y., Chen, H.-L., Nguyen, T. N. A., Liao, H.-T., Liu, M., Hagar, H. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165523 · Cited by 40 · see citing works

COVID-19 as a Risk Factor for Alzheimer’s Disease

Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39 · see citing works

Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Reduces Aberrant Tau Phosphorylation in an Alzheimer Disease Model

Lim, H., Lee, D., Choi, W.-K., Choi, S. J., Oh, W., & Kim, D. H. (2020) · Stem Cells International · doi:10.1155/2020/8878412 · Cited by 36 · see citing works

Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease

Qu, W., & Li, L. (2021) · The Neuroscientist · doi:10.1177/10738584211040786 · Cited by 37 · see citing works

Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease

Wang, W., Gopal, S., Pocock, R., & Xiao, Z. (2019) · Molecules · doi:10.3390/molecules24244604 · Cited by 35 · see citing works

Galectins and Their Ligand Glycoconjugates in the Central Nervous System Under Physiological and Pathological Conditions

Nio‐Kobayashi, J., & Itabashi, T. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.767330 · Cited by 34 · see citing works

Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors

Jayan, J., Chandran, N., Thekkantavida, A. C., Abdelgawad, M. A., Ghoneim, M. M., Shaker, M. E., Uniyal, P., Benny, F., Zachariah, S. M., Kumar, S., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c05883 · Cited by 34 · see citing works

Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities

Barake, F., Soza, A., & González, A. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000812 · Cited by 32 · see citing works

Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases

Tian, Y.-K., Ye, D.-W., Ge, M.-M., Chen, N., Zhou, Y.-Q., & Yang, H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201094547 · Cited by 31 · see citing works

Relationship between novel inflammatory biomarker galectin-3 and depression symptom severity in a large community-based sample

King, D. R., Salako, D. C., Arthur-Bentil, S. K., Rubin, A. E., Italiya, J. B., Tan, J. S., Macris, D. G., Neely, H. K., Palka, J. M., Grodin, J. L., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.050 · Cited by 29 · see citing works

Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations

Mijailović, N. R., Vesić, K., Arsenijević, D., Milojević‐Rakić, M., & Borovčanin, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.923811 · Cited by 29 · see citing works

Therapeutic potential of targeting galectins – A biomaterials-focused perspective

Martín‐Saldaña, S., Chevalier, M. T., & Pandit, A. S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121585 · Cited by 29 · see citing works

Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation

Luo, Y., Zhu, J., Hu, Z., Luo, W., Du, X., Hu, H., & Peng, S. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3841 · Cited by 28 · see citing works

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease

Torshizi, A. D., Truong, D. T., Hou, L., Smets, B., Whelan, C. D., & Li, S. (2024) · Nature Communications · doi:10.1038/s41467-024-50718-x · Cited by 26 · see citing works

Comparative analysis of vertebrates reveals that mouse primordial oocytes do not contain a Balbiani body

Dhandapani, L., Salzer, M. C., Duran, J. M., Zaffagnini, G., de Guirior, C., Martínez‐Zamora, M. Á., & Böke, E. (2021) · Journal of Cell Science · doi:10.1242/jcs.259394 · Cited by 26 · see citing works

Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling

Gabr, M. T., Rehman, A. U., & Chen, H. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00330 · Cited by 23 · see citing works

Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia

Bum‐Erdene, K., Collins, P. M., Hugo, M. W., Tarighat, S. S., Fei, F., Kishor, C., Leffler, H., Nilsson, U. J., Groffen, J., Grice, I. D., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01296 · Cited by 25 · see citing works

Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice

Yan, Q., Lv, J., Shen, X., Yang, J., Yang, J.-Z., Nie, R.-F., Lu, J., Huang, Y.-J., Wang, J.-Y., & Shen, X. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00857-4 · Cited by 25 · see citing works

Mapping the dynamics of insulin-responsive pathways in the blood–brain barrier endothelium using time-series transcriptomics data

Wang, Z., Tang, X., Swaminathan, S. K., Kandimalla, K. K., & Kalari, K. R. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00235-8 · Cited by 24 · see citing works

Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis

Ramos-Martínez, E. G., Ramos-Martínez, I. E., Sánchez‐Betancourt, J. I., Ramos-Martínez, J. C., Peña‐Corona, S. I., Valencia‐Ortega, J., Saucedo, R., Almeida-Aguirre, E. K. P., & Cerbón, M. A. (2022) · Biomolecules · doi:10.3390/biom12081062 · Cited by 23 · see citing works

Computational Interspecies Translation Between Alzheimer’s Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging

Lee, M. J., Wang, C., Carroll, M. J., Brubaker, D. K., Hyman, B. T., & Lauffenburger, D. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727784 · Cited by 18 · see citing works

Neuroinflammation and galectins: a key relationship in neurodegenerative diseases

Hernández, E. R., Olvera, B. A., González, D. C., Marín, O. G., Mercado, D. P., Gil, L. V., Hernández-Zimbrón, L. F., Sánchez‐Salgado, J. L., Limón, I. D., & Zenteno, E. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10064-w · Cited by 19 · see citing works

Senescence accelerated mouse-prone 8: a model of neuroinflammation and aging with features of sporadic Alzheimer’s disease

Ong, J. Y., Sasaki, K., Ferdousi, F., Suresh, M., Isoda, H., & Szele, F. G. (2025) · Stem Cells · doi:10.1093/stmcls/sxae091 · Cited by 18 · see citing works

Alzheimer's disease: Is there a role for galectins?

da Rosa, M. M., Ferreira, M. D. A., Lima, C. A. D. O., Mendonça, A. C. S., Silva, Y. M., Sharjeel, M., Rêgo, M. J. B. D. M., Pereira, M. C., & Pitta, M. G. D. R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174437 · Cited by 17 · see citing works

Galectin-3 Binding to α5β1 Integrin in Pore Suspended Biomembranes

Sarangi, N. K., Shafaq‐Zadah, M., Berselli, G. B., Robinson, J. B. D., Dransart, E., Cicco, A. D., Lévy, D., Johannes, L., & Keyes, T. E. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c05717 · Cited by 15 · see citing works

Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach

Li, H., Fan, Y., Shen, Y., Xu, H., Zhang, H., Chen, F., & Feng, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c01622 · Cited by 17 · see citing works

Experimental approaches for altering the expression of Abeta‐degrading enzymes

Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 17 · see citing works

Galectin-3 in T cell-mediated immunopathology and autoimmunity

Srejovic, I. M., & Lukić, M. L. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.03.009 · Cited by 15 · see citing works

Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4/NF-кB signaling in aged mice

Chen, F., Wu, X., Yang, J., Yu, X., Liu, B., & Yan, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175360 · Cited by 15 · see citing works

Alzheimer’s disease and immunotherapy

Qin, W., Pang, Y., Nie, S., Quan, M., & Jia, J. (2024) · Current Medicine · doi:10.1007/s44194-024-00035-8 · Cited by 15 · see citing works

A Novel Polysaccharide DSPP-1 from Durian Seed: Structure Characterization and Its Protective Effects Against Alzheimer’s Disease in a Transgenic Caenorhabditis elegans Model

Xiao, C., Chen, T., Yuan, M., Li, Y., & Wang, F. (2023) · Plant Foods for Human Nutrition · doi:10.1007/s11130-023-01059-5 · Cited by 14 · see citing works

An insight into the TAM system in Alzheimer’s disease

Zhou, S., Li, Y., Zhang, Z., & Yuan, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109791 · Cited by 13 · see citing works

The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease

Liu, X., Wu, W., Li, X., Wang, C., Chai, K., Yuan, F., Zheng, H., Yao, Y., Li, C., Ye, Z., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01890 · Cited by 13 · see citing works

The Anxiolytic Activity of Schinus terebinthifolia Leaf Lectin (SteLL) Is Dependent on Monoaminergic Signaling although Independent of the Carbohydrate-Binding Domain of the Lectin

de Lima, B. R. F., Patriota, L. L. D. S., Marinho, A. D. O., da Costa, J. A., Napoleão, T. H., da Rosa, M. M., & Paiva, P. M. G. (2022) · Pharmaceuticals · doi:10.3390/ph15111364 · Cited by 13 · see citing works

Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of Aβ1-42 Mice via α7nAChR-Dependent BDNF Upregulation

Cai, C., Wang, L., Li, S., Lou, S.-C., Luo, J., Fu, D., & Chen, T. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1989-21.2022 · Cited by 12 · see citing works

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease

Peng, Q., Zhang, G., Guo, X., Dai, L., Xiong, M., Zhang, Z., Chen, L., & Zhang, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1046992 · Cited by 12 · see citing works

The Proteome Content of Blood Clots Observed Under Different Conditions: Successful Role in Predicting Clot Amyloid(ogenicity)

Kell, D. B., & Pretorius, E. (2025) · Molecules · doi:10.3390/molecules30030668 · Cited by 12 · see citing works

Ratiometric Imaging of Mitochondrial Hydrogen Peroxide in Aβ42-Mediated Neurotoxicity

Li, X., Zhang, Y., & Ai, H. (2022) · ACS Sensors · doi:10.1021/acssensors.1c01381 · Cited by 12 · see citing works

Galectin-9 activates the TLR4-NLRP3 inflammasome pathway and promotes tau pathology in Alzheimer’s disease

Guo, X., Zhang, G., Peng, Q., Liu, H., Ye, K., Xiao, T., Liu, C., Zhang, X., Li, S., Wang, H., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106158 · Cited by 11 · see citing works

Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic

Simões, J. L. B., Sobierai, L. D., Leal, I. F., dos Santos, M. V. R., Coiado, J. V., & Bagatini, M. D. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.12.007 · Cited by 11 · see citing works

AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy

Liu, X., Xu, J., Zheng, S., Yang, Y., Xie, Y., Liu, J., Zhong, J., Zhang, H., Chen, J., Dai, C., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107834 · Cited by 10 · see citing works

Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice

Liu, X., Chen, P., Wu, W., Zhong, M., Dong, S., Lin, H., Dai, C., Zhang, Z., Lin, S., Che, C., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123085 · Cited by 9 · see citing works

Assessment of the Risk of Depression in Residents Staying at Long-Term Care Institutions in Poland During the COVID-19 Pandemic Depending on the Quality of Cognitive Functioning

Górski, M. K., Buczkowska, M., Grajek, M. K., Garbicz, J., Całyniuk, B., Szynal, K., Głuszek, A., & Polaniak, R. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.766675 · Cited by 9 · see citing works

Microglia‐derived Galectin‐9 drives amyloid‐β pathology in Alzheimer's disease

Zhang, G., Peng, Q., Guo, X., Pan, L., Xiong, M., Zhang, X., Dai, L., Zhang, Z., Xiao, T., He, J., et al. (2024) · Aging Cell · doi:10.1111/acel.14396 · Cited by 8 · see citing works

Multi-Scale Integration of Human Brain Vascular and CSF Proteomes Reveals Biomarkers of Cerebral Amyloid Angiopathy Linked to Alzheimer’s Disease RiskPreprint

Wojtas, A., Rathore, S., Dammer, E. B., Yu, L., Seifar, F., Gadhavi, J. D., Shantaraman, A., Duong, D. M., Wu, F., Liu, Y., et al. (2025) · medRxiv · doi:10.1101/2025.10.08.25337413 · Cited by 8 · see citing works

Pleiotropic regulatory mechanisms and targeted therapeutic prospects of Galectin-3 in aging-related diseases

Yuan, J., Dong, X., Gao, Y. L., & Nao, J. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00744 · Cited by 6 · see citing works

Glucose Metabolism, Lactate, Lactylation and Alzheimer’s Disease

Hai, S., Hou, Y., Zhang, M., Gao, X., Yang, T., Shang, X., & Sun, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0338 · Cited by 7 · see citing works

Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview

Borovčanin, M., Vesić, K., Jovanović, M., & Mijailović, N. R. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1731 · Cited by 6 · see citing works

Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding protein signaling pathway

Zhao, Y., Yang, W.-Q., Yu, L., Yang, J., Zhu, H.-R., & Zhang, L. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11248 · Cited by 6 · see citing works

Microglial galectin-3 increases with aging in the mouse hippocampus

Shin, H. J., Lee, S. J., An, H. S., Choi, H. N., Jeong, E. A., Lee, J. W., Kim, K. E., Choi, B.-H., Yun, S. P., Kang, D., et al. (2025) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.24.196 · Cited by 7 · see citing works

Association between sleep patterns and galectin-3 in a Chinese community population

Liu, L., Zhen, J., Liu, S., Ren, L., Zhao, G., Liang, J., Xu, A., Li, C., Wu, J., & Cheung, B. M. Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-18811-4 · Cited by 5 · see citing works

Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease

Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5 · see citing works

Sweet Aging: Glycocalyx and Galectins in CNS Aging and Neurodegenerative Disorders

Légrádi, Á., & Mir, M. Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104699 · Cited by 5 · see citing works

Microglia-mediated protection against Alzheimer’s disease pathology and detrimental effects in white matter revealed by Ptpn6 deletion

Etxeberría, A., Lee, S.-H., Kuhn, J., Callow, M. G., Novikova, G., Fortin, J., Choy, M. K., Xie, L., Imperio, J., Vito, S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.023 · Cited by 4 · see citing works

EGFR–Annexin A2 signaling–mediated tauopathy in amyloid-β and aluminum chloride–induced Alzheimer’s disease and its modulation by the HDAC inhibitor butyrate

Jayaswamy, P. K., Ambrish, T., Sangamesh, V. C., Kabekkodu, S. P., Kellarai, A., Shetty, J., & Shetty, P. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119775 · Cited by 4 · see citing works

Amyloid β oligomer promotes microglial galectin-3 and astrocytic lipocalin-2 levels in the hippocampus of mice fed a high-fat diet

Shin, H. J., Kim, K. E., Jeong, E. A., An, H. S., Lee, S. J., Lee, J., & Roh, G. S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.026 · Cited by 6 · see citing works

Exploring galectin-3’s role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs

Zhou, X., Dai, N., Yu, D., Niu, T., & Wang, S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1443133 · Cited by 4 · see citing works

Folding-Based End-To-End Chemical Drug Design with Uncertainty Estimation: Tackling Hallucination in the Post-GPT Era

Zhong, F., Yue, R., Chen, J.-X., Wang, D., Ma, S., & Chen, S. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00271 · Cited by 4 · see citing works

Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers

Li, W., Zhang, Y., Li, C., Jiang, M., Wang, D., Chao, L., & Yang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1615540 · Cited by 3 · see citing works

Could Galectin-3 be a key player in the etiology of neuromyelitis optica spectrum disorder?

Ramakrishnan, P. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110450 · Cited by 3 · see citing works

Integrated bioinformatics analysis and biological experiments to identify key immune genes in vascular dementia

Zhao, Y., Xing, W., Chen, W., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1560438 · Cited by 2 · see citing works

Fucoxanthin suppresses amyloid-β and pyroglutamate-3-Aβ accumulation by modulating the PI3K/Akt/GSK-3β signaling pathway

Lee, N., Youn, K., Kwon, H., Lee, J., Lee, E., Jung, J. W., Moon, M., Lee, D., Kim, D. H., Ho, C., et al. (2025) · Food & Function · doi:10.1039/d5fo04217h · Cited by 2 · see citing works

Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system

Siew, J. J., & Chern, Y. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107410 · Cited by 2 · see citing works

The Link Between COVID-19 and Alzheimer Disease Through Neuroinflammation

Nouraeinejad, A. (2023) · Clinical Medicine & Research · doi:10.3121/cmr.2023.1841 · Cited by 2 · see citing works

Exploring Multi-Faceted Bioactivity of Aβ42 Oligomers on Diverse Bio-Substrates: Implications for Alzheimer's Disease and Cerebral Amyloid Angiopathy

Huang, C.-J., Ho, S.-Y., Wu, S., Wang, Y., & Dong, G. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105570 · Cited by 2 · see citing works

Mouse oocytes do not contain a Balbiani bodyPreprint

Dhandapani, L., Salzer, M. C., Duran, J. M., Zaffagnini, G., Guirior, C. D., Martínez-Zamora, M. A., & Böke, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.01.429160 · Cited by 2 · see citing works

The bidirectional links between coronavirus disease 2019 and Alzheimer’s disease

Nouraeinejad, A. (2024) · International Journal of Neuroscience · doi:10.1080/00207454.2024.2327403 · Cited by 1 · see citing works

Novel role of NCoR1 in impairing spatial memory through the mediation of a novel interacting protein DEC2

Cheng, K.-M., Hsu, W.-L., Ma, Y., Liu, Y., & Lee, E. H. Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05321-0 · Cited by 1 · see citing works

Decoding NMDAR encephalitis: proteomic markers and computational identification of potential therapeutic pathways

Wang, S., Yuan, Y., Guo, X., Qin, M., Chen, J., Jiang, D., Feng, Y., & Mao, L. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106101 · Cited by 1 · see citing works

Galectin-3 in Alzheimer’s disease: pathological roles, biomarker potential, and therapeutic implications

Akash, A., Ahamed, M., Porel, P., & Aran, K. R. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149949 · Cited by 2 · see citing works

Galectin-3 shapes microglial phenotype through endogenous and exogenous mechanisms

Camprubí-Ferrer, L., Yang, Y., Fernández‐Calle, R., Boza‐Serrano, A., García‐Revilla, J., Frontiñán-Rubio, J., & Deierborg, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1729776 · Cited by 1 · see citing works

Berbamine hydrochloride as a brain-penetrant galectin-3 inhibitor in a model of Huntington’s disease

Siew, J. J., Lee, C., Chen, H.-M., Lin, H., Liu, Y.-L., Lee, Y.-H., Wu, Y. X., Chen, H.-L., Liu, F., Lin, C.-H., et al. (2026) · Brain · doi:10.1093/brain/awag069 · Cited by 1 · see citing works

Alzheimer's disease and COVID-19

Koberskaya, N. N., & Roshchin, P. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-6-89-97 · Cited by 1 · see citing works

Ai-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer's Disease TherapyPreprint

Ye, Z., Liu, X., Xu, J., Zheng, S., Zhong, J., Yang, Y., Xie, Y., Zhang, H., Chen, J., Dai, C., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5144196 · Cited by 1 · see citing works

A Novel polysaccharide DSPP-1 from Durian seed: structure characterization and its neuroprotective effects against Alzheimer's disease in a transgenic Caenorhabditis elegans modelPreprint

Xiao, C., Chen, T., Yuan, M., Li, Y., & Wang, F. (2022) · Research Square · doi:10.21203/rs.3.rs-2224001/v1

Galectin-3, A Novel Endogenous Trem2 Ligand, Regulates Inflammatory Response and Aβ Fibrilation in Alzheimer’s DiseasePreprint

Boza‐Serrano, A., Ruiz, R., Sanchez-Varo, R. M., Yang, Y., García‐Revilla, J., Jiménez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/477927

Potential Reversal of Alzheimer’s Disease pathology by Antibody TB006 Targeting Galectin‐3, the Root Cause of Oligomerization of Amyloid Proteins

Rasool, S., Patel, P., Johansson, J. U., Voloboueva, L. A., Lee, S., Sun, J. D., Lan, X., Ahmed, T., & Sun, D. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.060393 · Cited by 6 · see citing works

Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

Boza-Serrano, A., Ruiz, R., Sanchez-Varo, R., García-Revilla, J., Yang, Y., Jimenez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02013-z · Cited by 357 · see citing works

Galectin-3 Deletion Modulates Microglial Phenotype and Aβ Response via TREM2Activation While Attenuating NeuroinflammationPreprint

Camprubí-Ferrer, L., Soldán-Hidalgo, J., Axell, E., García-Cruzado, M., Yang, Y., Fernández‐Calle, R., Larlham, L., Chouhan, B. S., García‐Revilla, J., Talaverón, R., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5204277

Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processingPreprint

Camprubí-Ferrer, L., Soldán-Hidalgo, J., Axell, E., Dell’Eva, M., García-Cruzado, M., García‐Revilla, J., Yang, Y., Fernández‐Calle, R., Larlham, L., Chouhan, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.17.643790